- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03661268
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
January 27, 2021 updated by: Chengdu Fifth People's Hospital
Fluid challenge is often carried out in septic shock patients.
Its responsiveness usually requires invasive monitoring.
The pulmonary artery catheter(PAC) is the most effective means of monitoring.To use non-invasive methods is very tempting.
Investigators hypothesize that venous-to-arterial carbon dioxide difference,venous-to-arterial carbon oxygen difference, central venous-arterial carbon dioxide to arterial-venous oxygen content ratio and Central Venous SO2 variations provides feasible estimation on fluid responsiveness in septic shock patients.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: xiang xiang, MD
- Phone Number: +86-028-61702187
- Email: xiangxiang0711@foxmail.com
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 611130
- Recruiting
- ICU of Chengdu Fifth People's Hospital
-
Contact:
- xiang xiang, M.M
- Email: xiangxiang0711@foxmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- more than 18 years old; less than 75 years old ICU patients
- Septic shock
- Monitored with pulmonary artery catheter (Swan-Ganz catheter)
- The decision of fluid challenge made by the treating physician
Exclusion Criteria:
- Evidence of fluid overload
- Pregnancy
- Recently participated in other studies
- Severe heart failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Septic shock
Patients (at least 18 years of age, no more than 75 years old) with refractory hypotension secondary to sepsis who, at the discretion of treating physicians, required fluid challenge in the presence of pulmonary artery catheter.
Refractory hypotension was defined as need of vasopressors to maintain systolic blood pressure (SBP) no less than 90 mmHg despite adequate fluid resuscitation.
|
A bag of 500ml of normal saline is infused within 15 minutes using a bag pressurized to 300 mmHg.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cardiac index change
Time Frame: Immediately after fluid challenge
|
Fluid responsiveness: increase in CI of at least 10% after fluid challenge ;Fluid nonresponsiveness:no increase or increase in CI less than 10%.
|
Immediately after fluid challenge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: wang ping, MD, Chengdu Fifth People's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Anticipated)
February 28, 2021
Study Completion (Anticipated)
September 30, 2021
Study Registration Dates
First Submitted
September 2, 2018
First Submitted That Met QC Criteria
September 5, 2018
First Posted (Actual)
September 7, 2018
Study Record Updates
Last Update Posted (Actual)
January 28, 2021
Last Update Submitted That Met QC Criteria
January 27, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-002(yan)-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated...Recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
National Taiwan University HospitalBaxter Healthcare CorporationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityUnknown
Clinical Trials on fluid chanllenge
-
Assiut UniversityCompleted
-
Thammasat University HospitalRecruitingOsteoarthritis, Knee | Total Knee Arthroplasty | Oral Fluid ReplacementThailand
-
University of ArizonaCompleted
-
University of ZurichCompleted
-
University of California, DavisEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiabetic Ketoacidosis | Cerebral EdemaUnited States
-
Indiana UniversityState University of New York at BuffaloCompletedHyperthermia | Kidney Injury | Dehydration | Kidney Dysfunction | Hot Weather; Adverse EffectUnited States
-
St. Olavs HospitalSINTEF Health Research; National Competence Services for Ultrasound and Image-guided...CompletedGlioma | Brain NeoplasmsNorway
-
University Hospital Hradec KraloveUniversity Hospital PilsenCompletedSepsis | Septic Shock | Surgery | Endothelial Dysfunction | AnesthesiaCzechia
-
Seoul National University Bundang HospitalCompletedFastingKorea, Republic of
-
Beth Israel Deaconess Medical CenterWithdrawn